Drug reaction with eosinophilia and systemic symptoms and cytomegalovirus colitis

Ann Allergy Asthma Immunol. 2019 Oct;123(4):401-403. doi: 10.1016/j.anai.2019.07.024. Epub 2019 Jul 31.

Authors

Matthew Krummenacher¹, Tatjana Banovic², Frank Kette³, William Smith³, Pravin Hissaria²

Affiliations

¹ SA Pathology, Royal Adelaide Hospital, Adelaide, South Australia. Electronic address: matthew.krummenacher@sa.gov.au.
² SA Pathology, Royal Adelaide Hospital, Adelaide, South Australia.
³ Royal Adelaide Hospital, Adelaide, South Australia.

PMID: 31376489
DOI: 10.1016/j.anai.2019.07.024

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Anti-Bacterial Agents / adverse effects
Anti-Bacterial Agents / immunology*
Anti-Bacterial Agents / therapeutic use
Colitis / drug therapy
Colitis / virology
Cytomegalovirus / isolation & purification
Cytomegalovirus Infections / drug therapy
Drug Hypersensitivity Syndrome / immunology*
Drug Hypersensitivity Syndrome / pathology
Eosinophilia / immunology*
Ganciclovir / therapeutic use
Humans
Hypersensitivity, Delayed / immunology
Male
Nephritis, Interstitial / chemically induced
Nephritis, Interstitial / drug therapy
Nephritis, Interstitial / immunology
Vancomycin / adverse effects*
Vancomycin / immunology*
Vancomycin / therapeutic use
Virus Activation / immunology

Substances

Anti-Bacterial Agents
Vancomycin
Ganciclovir